Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,498 | -1,790 | -12,450 | -22,950 | -3,948 |
| Depreciation Amortization | 6,472 | 6,410 | 5,300 | 2,260 | 2,150 |
| Accounts receivable | -816 | N/A | N/A | N/A | N/A |
| Other Working Capital | -2,801 | -2,480 | -7 | 7,290 | -3,739 |
| Other Operating Activity | 448 | -1,020 | 6,157 | 4,750 | -263 |
| Operating Cash Flow | $805 | $1,120 | $-1,000 | $-8,650 | $-5,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,916 | -3,000 | -2,290 | -1,930 | -1,196 |
| Net Acquisitions | N/A | 0 | 0 | 10,220 | 0 |
| Other Investing Activity | 70 | 1,780 | -1,020 | 1,490 | -49 |
| Investing Cash Flow | $-5,846 | $-1,220 | $-3,310 | $9,780 | $-1,245 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 11,175 | N/A | N/A | N/A | N/A |
| Debt Repayment | -9,997 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 347 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -100 | 2,500 | -1,030 | 11,091 |
| Financing Cash Flow | $1,525 | $-100 | $2,500 | $-1,030 | $11,091 |
| Beginning Cash Position | 4,560 | 4,760 | 6,570 | 6,480 | 2,429 |
| End Cash Position | 1,044 | 4,560 | 4,760 | 6,570 | 6,475 |
| Net Cash Flow | $-3,516 | $-200 | $-1,810 | $90 | $4,046 |
| Free Cash Flow | |||||
| Operating Cash Flow | 805 | 1,120 | -1,000 | -8,650 | -5,800 |
| Capital Expenditure | -7,188 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -6,383 | 1,120 | -1,000 | -8,650 | -5,800 |